Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Cash on Hand 2019–2025
Lyell Immunopharma, Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Lyell Immunopharma, Inc. cash on hand as of December 31, 2025: 60.2M, a 43.01% decrease year-over-year.
- Lyell Immunopharma, Inc. cash on hand for 2025 were 60.2M, a 43.01% decrease from 2024.
- Lyell Immunopharma, Inc. cash on hand for 2024 were 105.6M, a 27.50% decrease from 2023.
- Lyell Immunopharma, Inc. cash on hand for 2023 were 145.6M, a 17.88% increase from 2022.
- Lyell Immunopharma, Inc. cash on hand for 2022 were 123.6M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lyell Immunopharma, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $60 |
| 2024 | $106 |
| 2023 | $146 |
| 2022 | $124 |
| 2021 | $294 |
| 2020 | $140 |
Lyell Immunopharma, Inc. Cash on Hand — FAQ
Lyell Immunopharma, Inc. (LYEL) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's cash on hand history?
The chart and table above show Lyell Immunopharma, Inc.'s cash on hand by year and by quarter, including the growth rate.